EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹16 Cr | ₹-3.10 Cr | ₹-2.64 Cr | ₹2.07 Cr | ₹-2.05 Cr |
What is the latest Cash Flow from Financing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹-3.10 Cr |
| Mar2023 | ₹-2.64 Cr |
| Mar2022 | ₹2.07 Cr |
| Mar2021 | ₹-2.05 Cr |
How is Cash Flow from Financing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | Positive | |
| Mar2024 | ₹-3.10 Cr | Negative | |
| Mar2023 | ₹-2.64 Cr | Negative | |
| Mar2022 | ₹2.07 Cr | Positive | |
| Mar2021 | ₹-2.05 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹290.4 Cr | -9.9% | 6.3% | -11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -9.9% |
6.3% |
-11.8% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses